Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
Public ClinicalTrials.gov record NCT00609622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Phase 2B Study Of Sunitinib Plus Oxaliplatin, 5-Fluorouracil And Leucovorin (FOLFOX) Versus Bevacizumab Plus FOLFOX As First-Line Treatment In Patients With Metastatic Colorectal Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare the safety and efficacy of sunitinib in combination with FOLFOX versus bevacizumab in combination with FOLFOX for the treatment of patients with metastatic colorectal cancer who have not been treated before.
Study identification
- NCT ID
- NCT00609622
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 191 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2008
- Primary completion
- Jun 30, 2011
- Completion
- Jun 30, 2011
- Last update posted
- Oct 10, 2012
2008 – 2011
United States locations
- U.S. sites
- 81
- U.S. states
- 19
- U.S. cities
- 68
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Fairhope | Alabama | 36532 | — |
| Pfizer Investigational Site | Mobile | Alabama | 36604 | — |
| Pfizer Investigational Site | Chandler | Arizona | 85224 | — |
| Pfizer Investigational Site | Mesa | Arizona | 85206 | — |
| Pfizer Investigational Site | Bentonville | Arkansas | 72712 | — |
| Pfizer Investigational Site | Fayetteville | Arkansas | 72703 | — |
| Pfizer Investigational Site | Hot Springs | Arkansas | 71913 | — |
| Pfizer Investigational Site | Bakersfield | California | 93309 | — |
| Pfizer Investigational Site | Fresno | California | 93720 | — |
| Pfizer Investigational Site | Fullerton | California | 92835 | — |
| Pfizer Investigational Site | Lancaster | California | 93534 | — |
| Pfizer Investigational Site | Los Angeles | California | 90095-1772 | — |
| Pfizer Investigational Site | Los Angeles | California | 90095-6984 | — |
| Pfizer Investigational Site | Los Angeles | California | 90095 | — |
| Pfizer Investigational Site | Mission Hills | California | 91345 | — |
| Pfizer Investigational Site | Northrige | California | 91325 | — |
| Pfizer Investigational Site | Oxnard | California | 93030 | — |
| Pfizer Investigational Site | Pasadena | California | 91105 | — |
| Pfizer Investigational Site | Redondo Beach | California | 90277 | — |
| Pfizer Investigational Site | Santa Barbara | California | 93105 | — |
| Pfizer Investigational Site | Santa Maria | California | 93454 | — |
| Pfizer Investigational Site | Santa Monica | California | 90404 | — |
| Pfizer Investigational Site | Solvang | California | 93436 | — |
| Pfizer Investigational Site | Valencia | California | 91355 | — |
| Pfizer Investigational Site | Aurora | Colorado | 80045 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20007 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32605 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32204 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32207 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32258 | — |
| Pfizer Investigational Site | Jacksonville Beach | Florida | 32250 | — |
| Pfizer Investigational Site | Jasonville | Florida | 32207 | — |
| Pfizer Investigational Site | Orange Park | Florida | 32073 | — |
| Pfizer Investigational Site | Palatka | Florida | 32177 | — |
| Pfizer Investigational Site | Saint Augustine | Florida | 32086 | — |
| Pfizer Investigational Site | Stuart | Florida | 34994 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30341 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Macon | Georgia | 31217 | — |
| Pfizer Investigational Site | Marietta | Georgia | 30060 | — |
| Pfizer Investigational Site | Sandy Springs | Georgia | 30342 | — |
| Pfizer Investigational Site | Maryville | Illinois | 62062 | — |
| Pfizer Investigational Site | Chanute | Kansas | 66720 | — |
| Pfizer Investigational Site | Dodge City | Kansas | 67801 | — |
| Pfizer Investigational Site | El Dorado | Kansas | 67042 | — |
| Pfizer Investigational Site | Independence | Kansas | 67301 | — |
| Pfizer Investigational Site | Kingman | Kansas | 67068 | — |
| Pfizer Investigational Site | Liberal | Kansas | 67905 | — |
| Pfizer Investigational Site | Newton | Kansas | 67114 | — |
| Pfizer Investigational Site | Parsons | Kansas | 67357 | — |
| Pfizer Investigational Site | Salina | Kansas | 67401 | — |
| Pfizer Investigational Site | Wellington | Kansas | 67152 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67208 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67214 | — |
| Pfizer Investigational Site | Winfield | Kansas | 67156 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21225 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21237 | — |
| Pfizer Investigational Site | Columbus | Mississippi | 39705 | — |
| Pfizer Investigational Site | Corinth | Mississippi | 38834 | — |
| Pfizer Investigational Site | Tupelo | Mississippi | 38801 | — |
| Pfizer Investigational Site | Columbia | Missouri | 65203 | — |
| Pfizer Investigational Site | Henderson | Nevada | 89052 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89128 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89148 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89169 | — |
| Pfizer Investigational Site | Norman | Oklahoma | 73071 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73102 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73109 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73120 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74133 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Pfizer Investigational Site | Portland | Oregon | 97227 | — |
| Pfizer Investigational Site | Meadowbrook | Pennsylvania | 19046 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19106 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Pfizer Investigational Site | Radnor | Pennsylvania | 19087 | — |
| Pfizer Investigational Site | Willow Grove | Pennsylvania | 19090 | — |
| Pfizer Investigational Site | Beaumont | Texas | 77701 | — |
| Pfizer Investigational Site | Lubbock | Texas | 79415 | — |
| Pfizer Investigational Site | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00609622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 10, 2012 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00609622 live on ClinicalTrials.gov.